David Li Sells 5,000 Shares of Ingevity (NYSE:NGVT) Stock

Key Points

  • CEO David Li sold 5,000 Ingevity shares for approximately $383,100 at an average price of $76.62, reducing his ownership by 3.56%. The sale was made under a pre-arranged Rule 10b5-1 trading plan.
  • Ingevity reported quarterly EPS of $1.74, exceeding analysts’ $1.33 estimate, while revenue reached $314.1 million. The company set fiscal 2026 EPS guidance at $5.00–$5.45.
  • Analysts maintain a consensus “Hold” rating, with an average price target of $80.00; institutional investors own 91.59% of the company’s shares.

Ingevity Corporation (NYSE:NGVT - Get Free Report) CEO David Li sold 5,000 shares of Ingevity stock in a transaction that occurred on Wednesday, August 12th. The stock was sold at an average price of $76.62, for a total transaction of $383,100.00. Following the transaction, the chief executive officer owned 135,636 shares in the company, valued at approximately $10,392,430.32. The trade was a 3.56% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Ingevity Price Performance

Shares of NYSE:NGVT opened at $76.53 on Friday. The company's fifty day moving average is $73.57 and its two-hundred day moving average is $71.65. The company has a quick ratio of 1.15, a current ratio of 1.61 and a debt-to-equity ratio of 22.52. Ingevity Corporation has a 12-month low of $45.85 and a 12-month high of $79.29. The company has a market cap of $2.63 billion, a P/E ratio of 52.06 and a beta of 1.16.

Ingevity (NYSE:NGVT - Get Free Report) last released its earnings results on Wednesday, July 29th. The company reported $1.74 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.33 by $0.41. The company had revenue of $314.10 million during the quarter, compared to analyst estimates of $312.20 million. Ingevity had a return on equity of 284.70% and a net margin of 4.65%.Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. Equities analysts expect that Ingevity Corporation will post 5.4 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In




NGVT has been the subject of several research analyst reports. Weiss Ratings raised Ingevity from a "sell (d-)" rating to a "hold (c-)" rating in a research note on Friday, July 31st. Wall Street Zen cut Ingevity from a "strong-buy" rating to a "buy" rating in a research note on Saturday, August 1st. Two analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to data from MarketBeat, Ingevity currently has an average rating of "Hold" and an average target price of $80.00.

View Our Latest Research Report on Ingevity

Institutional Investors Weigh In On Ingevity

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Global Retirement Partners LLC acquired a new stake in shares of Ingevity during the 4th quarter valued at $27,000. Meeder Asset Management Inc. acquired a new position in shares of Ingevity in the fourth quarter worth $33,000. Geneos Wealth Management Inc. increased its stake in shares of Ingevity by 85.8% in the second quarter. Geneos Wealth Management Inc. now owns 838 shares of the company's stock worth $36,000 after acquiring an additional 387 shares during the last quarter. Frazier Financial Advisors LLC purchased a new stake in shares of Ingevity during the second quarter worth $37,000. Finally, Headlands Technologies LLC purchased a new stake in shares of Ingevity during the second quarter worth $46,000. Hedge funds and other institutional investors own 91.59% of the company's stock.

About Ingevity

(Get Free Report)

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Ingevity?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Ingevity and related companies.
From Our Partners
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles